/People

Lawrence K. Cohen

Investor

Chief Executive Officer at Health2047 · Board director at Phenomix Sciences

Find your path to Lawrence

28 people in our graph share verified history with Lawrence — schools, employers, funds. One of them is your warm intro.

FRANK GRAZZINI IIunlockedLawrence: together at Phenomix Sciences
Lawrence: together at Phenomix Sciences
×10Lawrence: together at Health2047

About

Larry Cohen is CEO of Health2047, an experienced biotechnology leader focused on drug and platform development. He previously held executive roles at Kadmon Holdings, VIA Pharmaceuticals, Zyomyx, Progenitor, and Somatix, and holds a PhD in Microbiology from the University of Illinois with postdoctoral work at Dana-Farber and Harvard Medical School.

Board director at Phenomix Sciences

Intro paths

→

In turn, Lawrence can intro founders to Phenomix Sciences's investors below.

Phenomix Sciences's investors · 1

Co-founders at Phenomix Sciences

AAAndres Acosta

Colleagues at Health2047

Frequently asked questions

Who is Lawrence K. Cohen?
Larry Cohen is CEO of Health2047, an experienced biotechnology leader focused on drug and platform development. He previously held executive roles at Kadmon Holdings, VIA Pharmaceuticals, Zyomyx, Progenitor, and Somatix, and holds a PhD in Microbiology from the University of Illinois with postdoctoral work at Dana-Farber and Harvard Medical School.
Where does Lawrence K. Cohen work?
Lawrence K. Cohen is Chief Executive Officer at Health2047 and Board director at Phenomix Sciences.